BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

CARsgen Announces CT041 CAR T-cell Product Candidate Granted RMAT Designation by the FDA

With the RMAT designation, CT041 enjoys all the benefits of Fast Track and Breakthrough Therapy designations including early and intensive FDA guidance on ...

January 11, 2022 | News

CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China

Leveraging CanSinoBIO's industry-leading synthetic biotechnology and formulation technology platform, Menhycia™ covalently binds common pathogen...

January 10, 2022 | News

Nuance Pharma acquires Sino Health

Nuance Pharma ("Nuance"or the "Company"), a specialty care focused biopharma with late late-stage clinical programs and existing commercial operations, tod...

January 07, 2022 | News

Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002

A team of scientists led by Dr. Su-Jun Deng from biologics of Jemincare R&D Center, and another team of scientists from SIMM of CAS, led by P...

January 04, 2022 | News

Ascletis Expands Ritonavir Oral Tablet Production

Ritonavir oral tablet annual production capacity has been expanded to 100 million tablets and can be further rapidly expanded based on market demand - ASC...

January 03, 2022 | News

Biosyngen to commercialize immune cell therapeutics in China

The inauguration ceremony of Biosyngen Pte. Ltd., ("Biosyngen") joint projects and Biosyngen biological production base was held in China-Singapore&nb...

December 29, 2021 | News

WuXi Biologics, ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody

Within the partnership, ImmuneOncia will have access to WuXi Biologics' integrated services in cell line development, cell culture development, biologics m...

December 28, 2021 | News

WestVac BioPharma COVID-19 vaccine has achieved a significant progress against the Omicron

The vaccine belongs to the latest fifth generation vaccine technology, targeting the S-RBD protein of the COVID-19 mutant strain, the trimer subunit vaccin...

December 27, 2021 | News

Yiling Pharmaceutical's Patent Depression-resolving Drug Approved for Marketing in China

The drug is an innovative traditional Chinese medicine (TCM) independently developed by Yiling Pharmaceutical based on clinical practices, applicable to mi...

December 24, 2021 | News

BeiGene expands commercial portfolio in China

Strategic collaboration expected to advance clinical development of ociperlimab in combination with tislelizumab, including initiation and funding by Novar...

December 22, 2021 | News

TCM provides new alternatives for the fight against COVID-19

Dr. Chen Zhen, President of the Central and Eastern European Federation of Chinese Medicine Societies, said that the Hungarian Qihuang TCM Center prov...

December 22, 2021 | News

Antengene and XtalPi Announce AI-Driven R&D Collaboration

Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and ...

December 17, 2021 | News

Honeywell Solstice Propellant Receives NMPA Registration for China New Cosmetic Raw Materials

Spanning almost 1500-square-feet and conveniently located in Parkway Parade shopping mall, the clinic concept is the first-of-its kind in the group's entir...

December 14, 2021 | News

UK medical diagnostics firm strikes commercial licensing deal to help Parkinson’s diagnosis in China

· Artificial intelligence and wearable technology invented in UK is helping to diagnose and manage Pa...

December 14, 2021 | News

Stay Connected